Pfizer Increases Patient Engagement with mHealth Apps

Pfizer Increases Patient Engagement with mHealth Apps

For the past few years, pharmaceutical giants like Pfizer, Merck & Co., and Novartis have been investing in custom mHealth apps as a way to connect directly with patients and doctor networks. These mHealth apps help to increase doctor and patient engagement, gain valuable insight, and extend the reach of these important pharmaceutical brands.

To date, Pzifer has over 20 client-facing apps available through the US app store, including popular mHealth apps such as Quitter’s Circle —developed in collaboration with the American Lung Association—and Living With Cancer, BeLive, HemMobile, and Hemocraft.

Many of the apps include social elements to help patients access and maintain a community of care providers and supportive members to assist them with their battle against difficult circumstances like cigarette addiction and cancer. These apps are capable of integrating with wearable devices, such as fitness trackers, and offer patients the ability to review doctor instructions and connect with resources for their conditions.

Dennis Hancock, VP of Business Technology at Pfizer, summarized the company’s commitment during a recent interview. “We have a real opportunity when we leverage technology in conjunction with our medicines to potentially have a positive impact on patients and their quality of life. When you are as patient-focused as we are at Pfizer, these opportunities should be pursued.”

“Companies need to allow up-front time to really enable patients to put their thumbprint on the design to help ensure they see value in the app,” he added. “Also, they need to ensure that the app development teams are committed to a constant learning cycle where improvements are made on a regular basis, encourage feedback, and then act on it to make the app truly valuable to patients in a sustainable way — this is key to a successful app.”

Judy Sewards, Pfizer’s Vice President of Data and Digital Innovations, added her own perspective. “We recognize that the data shows patients expect meaningful digital solutions from us, and it is our obligation to deliver that,” she said. “When we think about it at Pfizer, we’re not thinking about what’s the next shiny thing, or what’s the next widget or what everyone else is doing, but looking through the lens of our patients as people. It’s about them, not about us. One, be useful. Second, be human. Make sure the solution is easy, friendly, and engages with them in the way they want to be engaged with. Finally, be committed. When we launch a solution, that’s not the end but really the beginning of our commitment to our patient and to our customers.”

In the race to increase engagement and add value to customer experience, pharmaceutical companies have been relying on mHealth apps to connect with the doctors and patients who prescribe and use their products in a variety of new ways, including mHealth solutions for quitting smoking, pursuing self-care through cancer treatments, or organizing doctor instructions and tracking side-effects.

Pharmaceutical mobile apps are making a difference in the way pharmaceutical brands are viewed, and the influence they have with consumers. Would you like to offer a custom app to your customers that will add value to their lives, improve their health, and help you to connect with them in a positive way?

In our EndPoint Modeling workshops, we help you to design every aspect of your app, providing you with a complete set of technical and nontechnical specification documents, as well as a clickable prototype. We offer competitive rates, and we guarantee that your project will be delivered on-budget and 100% to spec. We invite you to call or message us for more details. We’d love to hear about your next project.

Submit a Comment

Your email address will not be published. Required fields are marked *